Farampator
Alternative Names: CX 691; ORG 24448Latest Information Update: 18 Dec 2008
At a glance
- Originator Cortex Pharmaceuticals; University of California at Irvine
- Developer Organon
- Class Antidepressants; Antipsychotics; Neuroprotectants; Nootropics; Oxadiazoles; Piperidines; Small molecules
- Mechanism of Action AMPA receptor agonists; Glutamate agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder; Schizophrenia
Most Recent Events
- 19 Nov 2007 Organon has been acquired by Schering-Plough
- 17 Oct 2007 Final efficacy data from a clinical trial in healthy elderly volunteers presented at the 20th Annual Congress of the European College of Neuropsychopharmacology (ECNP-2007)
- 17 Jan 2001 Phase-I clinical trials for Psychotic disorders in USA (PO)